Semiparametric Estimation of Longitudinal Medical Cost Trajectory
DOI10.1080/01621459.2017.1361329zbMath1398.62342OpenAlexW2746331149WikidataQ92254303 ScholiaQ92254303MaRDI QIDQ4962425
Ya-Chen Tina Shih, Liang Li, Xuelin Huang, Yu Shen, Chih-Hsien Wu, Jing Ning
Publication date: 2 November 2018
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc6405224
Time series, auto-correlation, regression, etc. in statistics (GARCH) (62M10) Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in survival analysis and censored data (62N02)
Related Items (1)
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Longitudinal data analysis using generalized linear models
- On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data
- Medical cost trajectories and onsets of cancer and noncancer diseases in US elderly population
- Backward estimation of stochastic processes with failure events as time origins
- A random effects four-part model, with application to correlated medical costs
- Ignorability and coarse data
- Semiparametric regression during 2003--2007
- On the asymptotics of penalized spline smoothing
- Analyzing Microarray Gene Expression Data
- Analysis of Longitudinal Data in the Presence of Informative Observational Times and a Dependent Terminal Event, with Application to Medical Cost Data
- On the asymptotics of penalized splines
- Estimating Medical Costs from Incomplete Follow-Up Data
- Semiparametric Regression
- Linear regression analysis of censored medical costs
- Estimating medical costs with censored data
- Nonparametric Inference for Median Costs with Censored Data
- Theory for penalised spline regression
- Joint Modelling of Repeated Measurements and Time-to-Event Outcomes: Flexible Model Specification and Exact Likelihood Inference
- Longitudinal Data Analysis
This page was built for publication: Semiparametric Estimation of Longitudinal Medical Cost Trajectory